- Home
- LWAY vs RZLT Comparison
LWAY vs RZLT Comparison
Compare LWAY & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LWAY
- RZLT
- Stock Information
- Founded
- LWAY 1986
- RZLT 2010
- Country
- LWAY United States
- RZLT United States
- Employees
- LWAY N/A
- RZLT N/A
- Industry
- LWAY Packaged Foods
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- LWAY Consumer Staples
- RZLT Health Care
- Exchange
- LWAY Nasdaq
- RZLT Nasdaq
- Market Cap
- LWAY 376.4M
- RZLT 361.3M
- IPO Year
- LWAY 1987
- RZLT N/A
- Fundamental
- Price
- LWAY $29.80
- RZLT $6.50
- Analyst Decision
- LWAY Buy
- RZLT Strong Buy
- Analyst Count
- LWAY 2
- RZLT 5
- Target Price
- LWAY $33.00
- RZLT $12.50
- AVG Volume (30 Days)
- LWAY 75.4K
- RZLT 859.1K
- Earning Date
- LWAY 08-12-2025
- RZLT 09-18-2025
- Dividend Yield
- LWAY N/A
- RZLT N/A
- EPS Growth
- LWAY N/A
- RZLT N/A
- EPS
- LWAY 0.70
- RZLT N/A
- Revenue
- LWAY $193,021,000.00
- RZLT N/A
- Revenue This Year
- LWAY $12.53
- RZLT N/A
- Revenue Next Year
- LWAY $12.08
- RZLT N/A
- P/E Ratio
- LWAY $42.37
- RZLT N/A
- Revenue Growth
- LWAY 9.19
- RZLT N/A
- 52 Week Low
- LWAY $17.82
- RZLT $2.22
- 52 Week High
- LWAY $31.00
- RZLT $6.65
- Technical
- Relative Strength Index (RSI)
- LWAY 70.74
- RZLT 70.63
- Support Level
- LWAY $27.14
- RZLT $5.52
- Resistance Level
- LWAY $31.00
- RZLT $6.61
- Average True Range (ATR)
- LWAY 1.19
- RZLT 0.30
- MACD
- LWAY 0.33
- RZLT 0.02
- Stochastic Oscillator
- LWAY 81.51
- RZLT 89.91
About LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.